Less than 10% of all cases of ALS are associated with hexanucleotide expansions in C9orf72, or pathological mutations in SOD1, TARDBP or FUS. Moreover, such cases are clinically indistinguishable from apparently sporadic cases, and encompass the full range of clinical phenotypes. This evidence concerns the gene SOD1 and amyotrophic lateral sclerosis.